Effect of COVID-19 on 18 F-FDG PET/CT: Is there a need for considering COVID-19 status before planning 18 F-FDG PET/CT for oncological evaluation?

J Nucl Med Technol. 2021 Jul 9;jnmt.121.262145. doi: 10.2967/jnmt.121.262145. Online ahead of print.


Incidental detection of coronavirus disease-2019 (COVID-19) related lung changes in 18F-FDG PET/CT of oncology patients have been increasingly reported. Most of the case reports/series stressed upon the retrospective diagnosis of COVID-19 with the help of 18F-FDG PET/CT lung findings. In this case report, we introduce a different aspect of COVID-19 related lung changes in 18F-FDG PET/CT, interfering with the evaluation of metastatic lung lesions in patients with renal cell carcinoma.

Keywords: 18F-FDG PET/CT; COVID-19; Infectious Disease; Lung metastasis; Oncology: Lung; PET/CT; Renal cell carcinoma; Response Evaluation.